University of South Florida-Morsani College of Medicine

View Center Information
Show Recruiting Studies for:

CountryStateAddressCenterSummary
USAFL17 Davis BlvdUniversity of South Florida - 17 Davis Medical BuildingA Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
USAFL601 5th Street SouthUniversity of South Florida - All Children's HospitalAn open-label, multi-center study to evaluate the safety and pharmacokinetics of IGSC 20% administered for 6 months in subjects with primary immunodeficiency
USAFL13801 Bruce B Downs Blvd, Suite 505University of South Florida - Asthma, Allergy & Immunology Clinical Research UnitDouble-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD (ASCENT COPD)
USAFL4001 Fletcher Ave.University of South Florida - Byrd Alzheimer's InstituteA 4-Week, Double-blind, Placebo-controlled, Randomized, Multicenter, Crossover Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
USAFL4001 Fletcher Ave.University of South Florida - Byrd Alzheimer's InstituteA 4-Week, Double-blind, Placebo-controlled, Randomized, Multicenter, Crossover Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
USAFL13101 Bruce B Downs BlvdUniversity of South Florida - Children's Medical Service ClinicA Phase 2/3, Multicenter, Open-label, Multicohort, Two-Part Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co), Administered with an Optimized Background Regimen (BR) in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects
USAFL13330 USF Laurel DriveUniversity of South Florida - Morsani Center for Advance HealthcareAn Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.
USAFL13330 USF Laurel DrUniversity of South Florida - Morsani Center for Advanced Healthcare A Randomized, Double-blind, Double-dummy, Parallel-group Study Comparing the Efficacy and Safety of Ofatumumab Versus Teriflunomide in Patients With Relapsing Multiple Sclerosis.
USAFL13330 USF Laurel DrUniversity of South Florida - Morsani Center for Advanced HealthcareA 15-week, Phase 2, Double Blind, Randomized, Placebo-controlled, Flexible Dose Study To Investigate The Efficacy, Safety And Tolerability Of Pf-06649751 In Subjects With Early Stage Parkinson's Disease
USAFL13330 USF Laurel DrUniversity of South Florida - Morsani Center for Advanced HealthcareA 26-Week Randomized, Open-label, Active Controlled, Parallel-group, Study Assessing the Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin ± Pioglitazone, Followed by a Fixed Ratio Combination Single-arm 26-Week Extension Period
USAFL13330 USF Laurel DriveUniversity of South Florida - Morsani Center for Advanced HealthcareA multicenter open label uncontrolled study of the long term safety and efficacy of calcitriol 3mcg/g ointment applied twice daily for 26 weeks in pediatric subjects (2 to 17 years of age) with mild to moderate plaque psoriasis
USAFL13330 USF Laurel DrUniversity of South Florida - Morsani Center for Advanced HealthcareA Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Single Attack Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine
USAFL13330 USF Laurel DriveUniversity of South Florida - Morsani Center for Advanced HealthcareA Phase 3, Randomized, Double-Blind Study Comparing ABT-494 Monotherapy to Methotrexate (MTX) in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response to MTX
USAFL13330 USF Laurel DriveUniversity of South Florida - Morsani Center for Advanced HealthcareA Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intolerance to Biologic DMARDs (bDMARDs)
USAFL13330 USF Laurel Dr.University of South Florida - Morsani Center for Advanced HealthcareA Phase 3b/4 Randomized Double Blind Placebo Controlled Study Of Methotrexate (Mtx) Withdrawal In Subjects With Rheumatoid Arthritis (ra) Treated With Tofacitinib 11mg Modified Release (mr) Formulation
USAFL13330 USF Laurel DrUniversity of South Florida - Morsani Center for Advanced HealthcareA Phase IIb/III, Randomized, Double-blind, Placebo-controlled Trial of BHV-4157 in Adult Subjects With Spinocerebellar Ataxia
USAFL13330 USF Laurel DriveUniversity of South Florida - Morsani Center for Advanced HealthcareA Placebo-controlled Randomized Withdrawal Evaluation of the Efficacy and Safety of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis
USAFL13330 USF Laurel DriveUniversity of South Florida - Morsani Center for Advanced HealthcareA randomised, double-blind, placebo-controlled, proof-of concept, dose-ranging study of BI 655066 in patients with active psoriatic arthritis.
USAFL13330 USF Laurel Dr.University of South Florida - Morsani Center for Advanced HealthcareA Randomized, Double-blind, Parallel Group, Multicenter Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis (RA)
USAFL4001 Fletcher AveUniversity of South Florida - Morsani Center for Advanced HealthcareA Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
USAFL13330 USF Laurel DriveUniversity of South Florida - Morsani Center for Advanced HealthcareA study of subcutaneous immunoglobulin as chronic treatment for patients with chronic inflammatory demyelinating polyneuropathy
USAFL13330 USF Laurel DriveUniversity of South Florida - Morsani Center for Advanced HealthcareAn Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias
USAFL13330 USF Laurel DriveUniversity of South Florida - Morsani Center for Advanced HealthcareAn Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.
USAFL13330 USF Laurel DriveUniversity of South Florida - Morsani Center for Advanced HealthcareBlinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
USAFL13330 USF Laurel DrUniversity of South Florida - Morsani Center for Advanced HealthcarePhase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION)
USAFL13330 USF Laurel DrUniversity of South Florida - Morsani Center for Advanced HealthcarePhase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION)
USAFL13330 USF Laurel DriveUniversity of South Florida - Morsani Center for Advanced HealthcarePhase 3B/4 Randomized Safety Endpoint Study of 2 Doses of Tofacitinib in Comparison to a Tumor Necrosis Factor (TNF) Inhibitor in Subjects with Rheumatoid Arthritis
USAFL2 Tampa General Circle, Suite 5075University of South Florida - South Tampa Center for Advanced Healthcare A Phase IV Trial To Assess The Effectiveness Of Apixaban Compared With Usual Care Anticoagulation In Subjects With Non-valvular Atrial Fibrillation Undergoing Cardioversion
USAFL2 Tampa General CircleUniversity of South Florida - South Tampa Center for Advanced HealthcareA Double-Blind, Controlled Phase 2B Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Ischemic Stroke
USAFL2 Tampa General CircleUniversity of South Florida - South Tampa Center for Advanced HealthcareA Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase of Perampanel as Adjunctive Treatment in Subjects at Least 2 Years of Age With Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
USAFL2 Tampa General CircleUniversity of South Florida - South Tampa Center for Advanced HealthcareA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Evaluation of the Safety of N1539 Following Major Surgery
USAFL2 Tampa General CircleUniversity of South Florida - South Tampa Center for Advanced HealthcareA Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome
USAFL2 Tampa General CircleUniversity of South Florida - South Tampa Center for Advanced HealthcareEfficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
USAFL2 Tampa General CircleUniversity of South Florida - South Tampa Center for Advanced HealthcareGENETIC-AF: A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure
USAFL2 Tampa General CircleUniversity of South Florida - South Tampa Center for Advanced HealthcareImmunogenicity and Safety Study of GSK Biologicals' Priorix® Vaccine (209762) at an End of Shelf-life Potency Compared to Merck & Co., Inc.'s MMR Vaccine When Both Are Given on a 2-dose Schedule to Healthy Children in Their 2nd Year of Life
USAFL2 Tampa General CircleUniversity of South Florida - South Tampa Center for Advanced HealthcareLong-Term Registry of Patients With Urea Cycle Disorders (UCDs)
USAFL2 Tampa General CircleUniversity of South Florida - South Tampa Center for Advanced HealthcareMulticenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy
USAFL2 Tampa General CircleUniversity of South Florida - South Tampa Center for Advanced HealthcareRandomized study to compare the Cook Cervical Ripening Balloon plus Pitocin to Pitocin alone in PROM patients
USAFL1 Tampa General CircleUniversity of South Florida - Tampa General HospitalA double-blind, randomized, stratified, multi-center trial evaluating conventional and high dose oseltamivir in the treatment of immunocompromised patients with influenza
USAFL1 Tampa General CircleUniversity of South Florida - Tampa General HospitalA multicenter, randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety and tolerability of Serelaxin when added to standard therapy in acute heart failure patients
USAFL1 Tampa General CircleUniversity of South Florida - Tampa General HospitalA Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD)
USAFL1 Tampa General CircleUniversity of South Florida - Tampa General HospitalA Phase 1, Single-Administration Pharmacokinetic and Safety Study of Oral and IV Tedizolid Phosphate in Hospitalized Subjects 2 to 12 Years Old
USAFL1 Tampa General CircleUniversity of South Florida - Tampa General HospitalA Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Single Lobe Treatment of Severe Emphysema
USAFL1 Tampa General CircleUniversity of South Florida - Tampa General HospitalA Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of BAY 41-6551 as Adjunctive Therapy in Intubated and Mechanically-Ventilated Patients With Gram-Negative Pneumonia
USAFL1 Tampa General CircleUniversity of South Florida - Tampa General HospitalA Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
USAFL1 Tampa General CircleUniversity of South Florida - Tampa General HospitalAdaptResponse Clinical Trial
USAFL1 Tampa General CircleUniversity of South Florida - Tampa General HospitalEffects of Enteral Glutamine Supplementation on Mortality and Infectious Morbidity in Severely Burned Patients: a Multi-center Pilot Trial
USAFL1 Tampa General CircleUniversity of South Florida - Tampa General HospitalEvaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta
USAFL5 Tampa General CircleUniversity of South Florida - Tampa General Hospital Center of Research ExcellenceA Phase 3, Open-Label, Randomized, Multi-Center Study to Assess the Safety & Tolerability of an Induction, Titration, and Maintenance Dose Regimen of BMN 165 Self Administered by Adults w/Phenylketonuria
USAFL13330 USF Laurel DriveUniversity of South Florida - USF Diabetes CenterA Phase IV, Multicenter, Open-Label Study of the Immunogenicity of Nutropin AQ® V1.1 [Somatropin (rDNA Origin) Injection] Administered Daily to Naive Growth Hormone-Deficient Children
USAFL13330 USF Laurel Dr.University of South Florida - USF Diabetes CenterAntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
USAFL13330 USF Laurel Dr.University of South Florida - USF Diabetes CenterAntithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
USAFL13330 USF Laurel Dr.University of South Florida - USF Diabetes CenterCTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes
USAFL13330 USF Laurel Dr.University of South Florida - USF Diabetes CenterNatural History Study of the Development of Type 1 Diabetes
USAFL13330 USF Laurel Dr.University of South Florida - USF Diabetes CenterNatural History Study of the Development of Type 1 Diabetes
USAFL13330 USF Laurel Dr.University of South Florida - USF Diabetes CenterOral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
USAFL509 South Armenia Ave., 2nd FloorUniversity of South Florida - USF Florida Cardiovascular InstituteA Phase III, Double-blind, Randomized Placebo-controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in a Genetically Defined Population With a Recent Acute Coronary Syndrome (ACS): The Dal-GenE Trial
USAFL509 S Armenia Ave #200University of South Florida - USF Florida Cardiovascular InstituteAdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 30%=LVEF=35%
USAFL509 South Armenia Ave., 2nd FloorUniversity of South Florida - USF Florida Cardiovascular InstituteBarostim Neo® - Baroreflex Activation Therapy® for Heart Failure
USAFL4001 Fletcher AveUniversity of South Florida - USF Health Byrd Alzheimer's Institute A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia
USAFL4001 Fletcher AveUniversity of South Florida - USF Health Byrd Alzheimer's InstituteA 15-week, Phase 2, Double Blind, Randomized, Placebo-controlled, Flexible Dose Study To Investigate The Efficacy, Safety And Tolerability Of Pf-06649751 In Subjects With Early Stage Parkinson's Disease
USAFL4001 Fletcher AveUniversity of South Florida - USF Health Byrd Alzheimer's InstituteA Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
USAFL4001 Fletcher AvenueUniversity of South Florida - USF Health Byrd Alzheimer's InstituteA Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Crenezumab in patients with prodromal to mild Alzheimer's Disease.
USAFL4001 Fletcher AvenueUniversity of South Florida - USF Health Byrd Alzheimer's InstituteA Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects With Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal AD)
USAFL4001 E. Fletcher AveUniversity of South Florida - USF Health Byrd Alzheimer's InstituteA Randomized, Multiple Dose Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease
USAFL4001 Fletcher AvenueUniversity of South Florida - USF Health Byrd Alzheimer's InstituteAn Open-Label, Phase 3 Study Examining the Long-Term Safety, Tolerability and Efficacy of APL-130277 in Levodopa Responsive Patients with Parkinson’s Disease Complicated by Motor Fluctuations ("OFF" Episodes)
USAFL4001 Fletcher AvenueUniversity of South Florida - USF Health Byrd Alzheimer's InstituteTopiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
USAFL3515 E Fletcher AveUniversity of South Florida - USF Health Psychiatry CenterA Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI)
USAFL3515 E Fletcher AveUniversity of South Florida - USF Health Psychiatry CenterA Phase 3, double blind, randomized study of RVT-101 versus placebo when added to existing stable donepezil treatment in subjects with mild to moderate Alzheimer’s disease
USAFL3515 E Fletcher AveUniversity of South Florida - USF Health Psychiatry CenterA Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Molindone Hydrochloride Extended-Release Tablets for the Treatment of Impulsive Aggression in Pediatric Patients with Attention Deficit/Hyperactivity Disorder (ADHD) in Conjunction with Standard ADHD Treatment
USAFL3515 E Fletcher Ave.University of South Florida - USF Health Psychiatry CenterAn Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
USAFL501 6th Ave SouthUniversity of South Florida- All Children's HospitalEvaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
USAFL13801 Bruce B. Downs Blvd. #502University of South Florida- Asthma, Allergy, and Immunology Clinical Research UnitA Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Efficacy and Safety of STG320 Sublingual Tablets of House Dust Mite (HDM) Allergen Extracts in Adults and Adolescents With HDM-associated Allergic Rhinitis
USAFL13801 Bruce B. Downs Blvd. #502University of South Florida- Asthma, Allergy, and Immunology Clinical Research UnitA Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Efficacy and Safety of STG320 Sublingual Tablets of House Dust Mite (HDM) Allergen Extracts in Adults and Adolescents With HDM-associated Allergic Rhinitis
USAFL4001 East Fletcher AvenueUniversity of South Florida- Byrd Alzheimer's InstituteA Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
USAFL4001 East Fletcher AvenueUniversity of South Florida- Byrd Alzheimer's InstituteA Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
USAFL3515 E Fletcher AvenueUniversity of South Florida- Department of Psychiatry and Behavioral NeurosciencesA Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder (MDD)
USAFL3100 East Fletcher AvenueUniversity of South Florida- Florida Hospital TampaA Prospective, Single-Arm, Multi-Site, Clinical Evaluation of the SAVI SCOUT® Surgical Guidance System for the Location of Non-Palpable Breast Lesions During Excision
USAFL13330 USF Laurel DriveUniversity of South Florida- Morsani Center for Advanced HealthcareA Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedreich's Ataxia (MOXIe)
USAFL13330 USF Laurel DriveUniversity of South Florida- Morsani Center for Advanced HealthcareA Phase IIIB, Multicenter, Randomized, Parallel-Group, Open-Label Study to Evaluate the Effects of Ocrelizumab on Immune Responses in Patients With Relapsing Forms of Multiple Sclerosis
USAFL13330 USF Laurel DriveUniversity of South Florida- Morsani Center for Advanced HealthcareA Prospective, Observational, US-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma and Treated With Valchlor®
USAFL13330 USF Laurel DriveUniversity of South Florida- Morsani Center for Advanced HealthcareCREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zolendronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
USAFL13330 USF Laurel DriveUniversity of South Florida- Morsani Center for Advanced HealthcareCREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zolendronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
USAFL13330 USF Laurel DriveUniversity of South Florida- Morsani Center for Advanced HealthcareMethodology Study of Novel Electrophysiological, Physical, and Imaging Outcome Measures to Assess the Progression of Amyotrophic Lateral Sclerosis
USAFL13330 Laurel Dr.University of South Florida- Morsani Center for Advanced HealthcareMulticenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis (OPTIMUM)
USAFL13330 USF Laurel DriveUniversity of South Florida- Morsani Center for Advanced HealthcarePilot Study of a 3d Motion Device- Feasibility Assessment in Patients with Parkinson’s Disease and Friedreich’s Ataxia
USAFL13330 USF Laurel DriveUniversity of South Florida -Morsani Center for Advanced HealthcareA Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Laquinimod (0.5, 1.0 and 1.5 mg/day) as Treatment in Patients with Huntington's Disease
USAFL13330 USF Laurel DriveUniversity of South Florida -Morsani Center for Advanced HealthcareEfficacy and Safety of Faster-acting Insulin Aspart compared to NovoRapid® both in Combination with Insulin Degludec in Children and Adolescents with Type 1 Diabetes
USAFL13330 USF Laurel DriveUniversity of South Florida- Morsani Center for Advanced Healthcare- Ataxia Research Center and Human Functional Performance LaboratoryLongitudinal Gait and Balance Measurement
USAFL800 6th Street SouthUniversity of South Florida- Rothman Center for Pediatric NeuropsychiatryA Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
USAFL800 6th Street SouthUniversity of South Florida- Rothman Center for Pediatric NeuropsychiatryA Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
USAFL2 Tampa General CircleUniversity of South Florida- South Tampa Center for Advanced Healthcare Randomized, Double-blind, Evaluation in Secondary Stroke Prevention Comparing the EfficaCy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, Oral b.i.d.) Versus Acetylsalicylic Acid (100 mg Oral q.d.) in Patients With Embolic Stroke of Undetermined Source (RESPECT ESUS)
USAFL1 Tampa General CircleUniversity of South Florida- South Tampa Center For Advanced HealthcareA Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
USAFL2 Tampa General CircleUniversity of South Florida- South Tampa Center For Advanced HealthcareA Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
USAFL2 Tampa General CircleUniversity of South Florida- South Tampa Center for Advanced HealthcareAn observational, multi-center study to evaluate the safety of deferasirox in the treatment of pediatric patients with non-transfusion-dependent iron overload.
USAFL2 Tampa General CircleUniversity of South Florida- South Tampa Center For Advanced HealthcareRare disease registries for certain lysosomal storage disorders, including, but not limited to, Fabry, Gaucher, MPS I, and Pompe diseases (each, a Registry)
USAFL1 Tampa General CircleUniversity of South Florida- Tampa General HospitalInspire® Upper Airway Stimulation System (UAS): Post-Approval Study
USAFL13127 Magnolia DriveUniversity of South Florida- USF Eye InstituteSafety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration- CEDAR STUDY
USAFL4001 East Fletcher AvenueUSF Health Byrd Alzheimer's InstituteA Phase III, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study Comparing the Efficacy and Safety of gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) to Immediate Release CD/LD in Fluctuating Parkinson's Disease Patients

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.